Die Übersetzung dieser Seite ist experimentell und in Entwicklung. Wir freuen uns über Ihr !
4007 Aktienübersicht
Die Al Hammadi Holding Company, ein Gesundheitskonzern, bietet im Königreich Saudi-Arabien verschiedene medizinische Dienstleistungen an.
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 3/6 |
Past Performance | 3/6 |
Financial Health | 6/6 |
Dividends | 3/6 |
Al Hammadi Holding Company Wettbewerber
Preisentwicklung & Leistung
Historical stock prices | |
---|---|
Current Share Price | ر.س48.95 |
52 Week High | ر.س71.80 |
52 Week Low | ر.س47.90 |
Beta | 0.46 |
1 Month Change | -10.84% |
3 Month Change | -24.69% |
1 Year Change | -7.12% |
3 Year Change | 77.36% |
5 Year Change | 185.01% |
Change since IPO | 239.05% |
Aktuelle Nachrichten und Updates
Here's Why We Think Al Hammadi Holding (TADAWUL:4007) Might Deserve Your Attention Today
May 21Investor Optimism Abounds Al Hammadi Holding Company (TADAWUL:4007) But Growth Is Lacking
Apr 23Al Hammadi Holding (TADAWUL:4007) Is Paying Out A Dividend Of SAR0.35
Mar 25Recent updates
Here's Why We Think Al Hammadi Holding (TADAWUL:4007) Might Deserve Your Attention Today
May 21Investor Optimism Abounds Al Hammadi Holding Company (TADAWUL:4007) But Growth Is Lacking
Apr 23Al Hammadi Holding (TADAWUL:4007) Is Paying Out A Dividend Of SAR0.35
Mar 25The Return Trends At Al Hammadi Holding (TADAWUL:4007) Look Promising
Feb 08Should You Be Adding Al Hammadi Holding (TADAWUL:4007) To Your Watchlist Today?
Jan 18There's Reason For Concern Over Al Hammadi Holding Company's (TADAWUL:4007) Price
Dec 28Should You Be Adding Al Hammadi Holding (TADAWUL:4007) To Your Watchlist Today?
Oct 19We Like These Underlying Return On Capital Trends At Al Hammadi Holding (TADAWUL:4007)
Sep 23If EPS Growth Is Important To You, Al Hammadi Holding (TADAWUL:4007) Presents An Opportunity
Jul 19There's Been No Shortage Of Growth Recently For Al Hammadi Holding's (TADAWUL:4007) Returns On Capital
Jun 19Here's Why We Think Al Hammadi Holding (TADAWUL:4007) Is Well Worth Watching
Apr 14Returns On Capital Are Showing Encouraging Signs At Al Hammadi Holding (TADAWUL:4007)
Mar 09Here's Why We Think Al Hammadi Holding (TADAWUL:4007) Might Deserve Your Attention Today
Jan 06Are Investors Undervaluing Al Hammadi Holding Company (TADAWUL:4007) By 30%?
Oct 25Does Al Hammadi Holding (TADAWUL:4007) Deserve A Spot On Your Watchlist?
Sep 14Is There An Opportunity With Al Hammadi Company For Development and Investment's (TADAWUL:4007) 46% Undervaluation?
Jul 22Al Hammadi Company For Development and Investment's (TADAWUL:4007) Returns On Capital Are Heading Higher
Jul 05Here's Why I Think Al Hammadi Company For Development and Investment (TADAWUL:4007) Might Deserve Your Attention Today
Jun 10Al Hammadi Company For Development and Investment (TADAWUL:4007) Is Looking To Continue Growing Its Returns On Capital
Mar 09This Analyst Just Downgraded Their Al Hammadi Company For Development and Investment (TADAWUL:4007) EPS Forecasts
Feb 02I Ran A Stock Scan For Earnings Growth And Al Hammadi Company For Development and Investment (TADAWUL:4007) Passed With Ease
Jan 17Returns On Capital At Al Hammadi Company For Development and Investment (TADAWUL:4007) Have Stalled
Nov 17Estimating The Fair Value Of Al Hammadi Company For Development and Investment (TADAWUL:4007)
Sep 23If You Like EPS Growth Then Check Out Al Hammadi Company For Development and Investment (TADAWUL:4007) Before It's Too Late
Aug 10The Returns At Al Hammadi Company For Development and Investment (TADAWUL:4007) Aren't Growing
Jul 20Read This Before Buying Al Hammadi Company For Development and Investment (TADAWUL:4007) For Its Dividend
May 03Slowing Rates Of Return At Al Hammadi Company For Development and Investment (TADAWUL:4007) Leave Little Room For Excitement
Apr 20Calculating The Fair Value Of Al Hammadi Company For Development and Investment (TADAWUL:4007)
Apr 05What Percentage Of Al Hammadi Company For Development and Investment (TADAWUL:4007) Shares Do Insiders Own?
Mar 19I Ran A Stock Scan For Earnings Growth And Al Hammadi Company For Development and Investment (TADAWUL:4007) Passed With Ease
Mar 04Al Hammadi Company For Development and Investment (TADAWUL:4007) Share Prices Have Dropped 30% In The Last Five Years
Feb 17Is Al Hammadi Company For Development and Investment's (TADAWUL:4007) Stock On A Downtrend As A Result Of Its Poor Financials?
Feb 02Here's What To Make Of Al Hammadi Company For Development and Investment's (TADAWUL:4007) Returns On Capital
Jan 17Estimating The Intrinsic Value Of Al Hammadi Company For Development and Investment (TADAWUL:4007)
Jan 01Could The Al Hammadi Company For Development and Investment (TADAWUL:4007) Ownership Structure Tell Us Something Useful?
Dec 16If You Like EPS Growth Then Check Out Al Hammadi Company For Development and Investment (TADAWUL:4007) Before It's Too Late
Dec 01Aktionärsrenditen
4007 | SA Healthcare | SA Markt | |
---|---|---|---|
7D | -1.7% | 2.3% | -1.5% |
1Y | -7.1% | 8.8% | -6.4% |
Rendite im Vergleich zur Industrie: 4007 unter dem Niveau der Branche SA Healthcare, die im vergangenen Jahr eine Rendite von 7.5% erzielte.
Rendite vs. Markt: 4007 entspricht dem SA Markt, der im vergangenen Jahr eine Rendite von -6.4 erzielte.
Preisvolatilität
4007 volatility | |
---|---|
4007 Average Weekly Movement | 4.0% |
Healthcare Industry Average Movement | 4.8% |
Market Average Movement | 4.9% |
10% most volatile stocks in SA Market | 7.8% |
10% least volatile stocks in SA Market | 2.5% |
Stabiler Aktienkurs: 4007Der Aktienkurs des Unternehmens war in den letzten 3 Monaten unbeständig.
Volatilität im Zeitverlauf: 4007Die wöchentliche Volatilität (4%) ist im vergangenen Jahr stabil geblieben.
Über das Unternehmen
Gegründet | Mitarbeiter | CEO | Website |
---|---|---|---|
1985 | n/a | Mohammad Bin Saleh Bin Al Hammadi | www.alhammadi.com |
Die Al Hammadi Holding Company, ein Gesundheitskonzern, bietet im Königreich Saudi-Arabien verschiedene medizinische Dienstleistungen an. Das Unternehmen ist in den Segmenten medizinische Dienstleistungen und pharmazeutische Produkte tätig. Es beschäftigt sich mit dem Verkauf von pharmazeutischen Produkten.
Al Hammadi Holding Company's Grundlagenzusammenfassung
4007 grundlegende Statistiken | |
---|---|
Marktanteil | ر.س7.96b |
Gewinn(TTM) | ر.س285.95m |
Umsatz(TTM) | ر.س1.16b |
27.4x
Kurs-Gewinn-Verhältnis6.8x
Kurs-Umsatz-VerhältnisIst 4007 zu teuer?
Siehe Fair Value und BewertungsanalyseErträge & Einnahmen
4007 Gewinn- und Verlustrechnung (TTM) | |
---|---|
Einnahmen | ر.س1.16b |
Kosten der Einnahmen | ر.س751.74m |
Bruttogewinn | ر.س403.46m |
Sonstige Ausgaben | ر.س117.52m |
Umsatz | ر.س285.95m |
Zuletzt gemeldete Gewinne
Mar 31, 2024
Datum des nächsten Gewinnberichts
k.A.
Gewinn per Aktie (EPS) | 1.79 |
Bruttomarge | 34.93% |
Nettogewinnspanne | 24.75% |
Schulden/Eigenkapital-Verhältnis | 10.5% |
Wie hat sich 4007 auf lange Sicht entwickelt?
Historische Performance und Vergleiche